during the fast evolving industry of most cancers therapeutics, comprehending the intricate mechanisms of Antibody-Drug Conjugates (ADCs) is important for producing efficient treatments. One of the most promising methods is the use of in vitro bystander result assays, which play a pivotal position in boosting therapeutic efficacy. These assays, pro